Skip to main content
    L

    Labcorp Holdings Inc. (LH)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NYSE

    $372.49
    +2.01 (+0.54%)

    Market Cap: $30.08B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Labcorp Holdings Inc. (LH) Financials: Revenue, Profit and Cash Flow

    Updated Oct 28, 2026. Financial statements from company filings, amounts in US dollars.

    Labcorp Holdings reported revenue of $13.95B for the fiscal year ended Dec 31, 2025, up 7.2% from the year before. That year, net income was $877.70M with a net margin of 6.3%, operating cash flow was $1.64B and free cash flow was $1.21B. The quarter ended Sep 30, 2026 had revenue of $3.81B and net income of $263.10M.

    Revenue and Margins

    The operating margin was 9.9% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $9.55B, a compound annual rate of 4.3%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$13.95B+7.2%28.8%9.9%6.3%
    Dec 2024$13.01B+7.0%27.9%8.4%5.7%
    Dec 2023$12.16B+2.5%27.7%6.0%3.4%
    Dec 2022$11.86B-9.7%31.3%12.1%10.8%
    Dec 2021$13.14B-6.0%38.0%23.2%18.1%
    Dec 2020$13.98B+21.0%35.4%17.5%11.1%
    Dec 2019$11.55B+2.0%28.1%11.5%7.1%
    Dec 2018$11.33B+9.9%28.0%11.7%7.8%
    Dec 2017$10.31B+7.9%30.0%12.7%12.0%
    Dec 2016$9.55BN/A29.9%13.3%7.5%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income rose 17.5% from the year before. In the quarter ended Sep 2026, net income rose 0.6% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$13.95B$13.01B$12.16B$11.86B$13.14B$13.98B$11.55B$11.33B$10.31B$9.55B
    Cost of revenue$9.94B$9.38B$8.80B$8.15B$8.14B$9.03B$8.30B$8.16B$7.22B$6.70B
    Gross profit$4.01B$3.62B$3.36B$3.71B$4.99B$4.95B$3.25B$3.18B$3.09B$2.85B
    Operating income$1.38B$1.09B$725.60M$1.44B$3.05B$2.45B$1.33B$1.33B$1.31B$1.27B
    Net income$877.70M$747.10M$419.20M$1.28B$2.38B$1.56B$824.90M$883.90M$1.23B$712.90M
    EBITDA$2.01B$1.79B$1.32B$1.94B$3.81B$3.24B$2.10B$2.05B$1.83B$1.78B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$3.81B$3.73B$3.54B$3.52B$3.56B$3.53B$3.35B$3.33B$3.28B$3.22B$3.18B$3.03B
    Gross profit$1.11B$1.11B$1.01B$993.20M$1.03B$1.05B$948.00M$896.30M$904.40M$926.40M$897.30M$821.40M
    Operating income$402.10M$451.60M$380.80M$267.60M$396.60M$394.50M$326.00M$216.50M$254.10M$294.80M$321.30M-$122.80M
    Net income$263.10M$299.10M$278.00M$164.90M$261.50M$238.30M$213.00M$143.60M$169.60M$205.60M$228.30M-$166.80M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $5.58B exceeded cash and equivalents by $5.05B.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$18.39B$18.38B$16.73B$20.16B$20.39B$20.07B$18.05B$16.19B$16.67B$14.25B
    Current assets$4.02B$4.81B$3.77B$4.63B$5.33B$5.13B$2.98B$2.84B$2.73B$2.48B
    Cash and equivalents$532.30M$1.52B$536.80M$320.60M$1.47B$1.32B$337.50M$426.80M$316.60M$433.60M
    Total liabilities$9.76B$10.31B$8.83B$10.06B$10.09B$10.61B$10.46B$9.19B$9.76B$8.73B
    Short-term debt$500.10M$1.00B$999.80M$301.30M$1.50M$376.70M$415.20M$10.00M$417.50M$549.50M
    Long-term debt$5.08B$5.33B$4.05B$5.04B$5.42B$5.42B$5.79B$5.99B$6.34B$5.30B
    Shareholder equity$8.62B$8.05B$7.88B$10.10B$10.27B$9.44B$7.57B$6.97B$6.82B$5.52B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$18.92B$18.53B$19.09B$18.39B$18.26B$18.06B$17.60B$18.38B$18.61B$16.71B$16.53B$16.73B
    Total liabilities$10.06B$9.91B$10.34B$9.76B$9.55B$9.57B$9.28B$10.31B$10.43B$8.69B$8.56B$8.83B
    Cash and equivalents$261.80M$141.80M$981.10M$532.30M$598.10M$647.30M$369.40M$1.52B$1.52B$265.10M$99.30M$536.80M
    Shareholder equity$8.85B$8.61B$8.73B$8.62B$8.70B$8.47B$8.31B$8.05B$8.17B$8.01B$7.96B$7.88B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 73.8% of operating cash flow. Dividends and share repurchases together came to 57.1% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$1.64B$1.59B$1.33B$1.96B$3.11B$2.14B$1.44B$1.31B$1.50B$1.20B
    Capital expenditures$434.50M$489.90M$453.60M$429.30M$421.50M$381.70M$400.20M$379.80M$312.90M$278.90M
    Free cash flow$1.21B$1.10B$874.10M$1.53B$2.69B$1.75B$1.04B$925.60M$1.19B$918.20M
    Dividends paid$240.70M$243.10M$254.00M$195.20M$1.00B$151.70M$2.40B$467.20M$3.34B$2.10M
    Share repurchases$450.00M$250.10M$1.00B$1.10B$1.67B$100.00M$450.00M$700.00M$338.10M$43.90M
    Investing cash flow-$1.19B-$1.37B-$1.17B-$1.65B-$884.60M-$643.20M-$1.28B$206.70M-$2.23B-$795.70M
    Financing cash flow-$1.46B$779.90M-$59.30M-$1.32B-$2.07B-$517.40M-$252.70M-$1.39B$593.20M-$671.00M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$563.80M$445.50M$191.50M$614.20M$387.20M$620.60M$18.50M$777.20M$277.30M$561.10M-$29.80M$579.60M
    Capital expenditures$151.60M$131.60M$121.00M$123.90M$106.70M$77.90M$126.00M$112.10M$115.80M$128.20M$133.80M$167.20M
    Free cash flow$412.20M$313.90M$70.50M$490.30M$280.50M$542.70M-$107.50M$665.10M$161.50M$432.90M-$163.60M$412.40M
    Last 12 quarters

    Frequently Asked Questions About LH

    What is Labcorp Holdings' annual revenue?

    Labcorp Holdings reported revenue of $13.95B for the fiscal year ended Dec 31, 2025.

    How fast is Labcorp Holdings' revenue growing?

    Revenue was up 7.2% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 5.6%.

    Is Labcorp Holdings profitable?

    Yes. Labcorp Holdings reported net income of $877.70M for the fiscal year ended Dec 31, 2025, with a net margin of 6.3%.

    How much free cash flow does LH generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $1.64B minus capital expenditures of $434.50M produced free cash flow of $1.21B.

    How much debt does Labcorp Holdings have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $5.08B, short-term debt of $500.10M and cash and equivalents of $532.30M.